Catalyst Wire Dossier Catalyst Wire Dossier

Brivaracetam (Briviact)

brivaracetam · UCB Pharma SA
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Brivaracetam (Briviact), covering 2015-04-13 to 2015-05-18. Get the full timeline:

Most recent: Clinical Trial Update: Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults [Phase 3]

See pricing